Medicus Pharma enters $5.1M warrant inducement; issues new warrants for 4M shares

Medicus Pharma Ltd.

Gross proceeds ~$5.1M from exercise of 2,680,000 existing warrants at amended price of $1.92/share.
Issued new unregistered Series C/D warrants to purchase 4,020,000 common shares at $2.00, expiring June 5, 2031.
Company agreed to file resale registration statement for new warrant shares within 60 days of agreement.
Also reported SEPA sales of 680,893 common shares for ~$1.5M from Oct 28 to Dec 4, 2025.
Maxim Group LLC acted as exclusive financial advisor; 6.0% cash fee on gross proceeds.

item 1.01item 3.02item 7.01item 1.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.